Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study

Table 1 Clinical response of 19 patients treated by DC vaccine.

Patients	Cases	Difference in copies of HBV-DNA between pre- and post-treatment (mean±SD)	Rate of negative for HBeAg (%)	Rate of HBeAg/anti-HBe conversion (%)
Responder	11	3.074±2.397	91 (10/11)	45.5 (5/11)
Non-responder	8	-0.021±0.495	0 (0/8)	0 (0/8)
All patients	191	1.771±2.39b	52.6 (10/19)	26.3 (5/19)

¹: total response rate = 57.9% (11/19);

^bP<0.01 (pair-matching t test: t = 3.13): Comparison analysis of the HBV-DNA copies of all patients between pre- and post-treatment.

Table 2 Relation between pre-treatment ALT and result of clinical response (cases).

Patients	ALT
	Normal	Nomal-2×ULN	>2×ULN
Responder	1	3	7
Non-responder	2	1	5